Glazer Capital LLC’s DermTech, Inc. Common Stock DMTK Stock Holding History

Glazer Capital LLC’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-147,797	Closed	-$3.02M	–	162
2018 Q4	$3.02M	Sell	147,797 -20,796	-12%	-$422K	0.42%	54
2018 Q3	$3.41M	Buy	168,593 +168,528	+259,274%	+$3.39M	0.36%	61
2018 Q2	$1K	Buy	+65	New	+$1.29K	﹤0.01%	145

Other funds holding DMTK

Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return

Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Glazer Capital LLC's DMTK Position: Q1 2019 in Review

Glazer Capital LLC sold out of DermTech, Inc. Common Stock (DMTK) in Q1 2019, closing a stake of 147,797 shares — an estimated $3.02M sold.

Glazer Capital LLC first reported a position in DMTK in Q2 2018 and held it in 3 quarters. The position peaked at $3.41M in Q3 2018. 5 funds tracked by Wall St. Rank hold DMTK as of Q1 2019.

Glazer Capital LLC reported no remaining DermTech, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
Glazer Capital LLC sold 147,797 DermTech, Inc. Common Stock shares in Q1 2019, an estimated $3.02M.
Glazer Capital LLC first reported a position in DermTech, Inc. Common Stock in Q2 2018 and held it in 3 quarters.
Glazer Capital LLC's DermTech, Inc. Common Stock position peaked at $3.41M in Q3 2018.
5 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q1 2019.

Based on Glazer Capital LLC's 13F filing for Q1 2019, filed 15 May 2019.